Novacyt (NCYT) News Today GBX 48.10 -1.60 (-3.22%) (As of 10:02 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Novacyt S.A. (NVYTF) Q2 2024 Earnings Call TranscriptSeptember 28, 2024 | seekingalpha.comNovacyt (LON:NCYT) Trading Up 12.8%Novacyt (LON:NCYT) Stock Price Up 12.8%September 17, 2024 | marketbeat.comNovacyt Share Chat (NCYT)September 16, 2024 | lse.co.ukNovacyt (LON:NCYT) Trading Up 9.9%Novacyt (LON:NCYT) Stock Price Up 9.9%August 30, 2024 | marketbeat.comCiti Fun 26 Share ChatAugust 28, 2024 | lse.co.ukNovacyt (LON:NCYT) Stock Price Down 14%Novacyt (LON:NCYT) Trading Down 14%August 27, 2024 | marketbeat.comMike Lynch's family devastated and in shock, says spokespersonAugust 25, 2024 | lse.co.ukTOP NEWS: UK retail sales rise in July amid triple sports boostAugust 16, 2024 | lse.co.ukLONDON MARKET EARLY CALL: Stocks called up after New York boostAugust 16, 2024 | lse.co.ukNovacyt SA ALNOVMay 22, 2024 | morningstar.comLong Term Incentive PlanApril 23, 2024 | actusnews.comDHSC Claim update - Pre-Trial ReviewApril 19, 2024 | actusnews.comAstraZeneca increases 2024 dividend by 7%April 13, 2024 | lse.co.ukDirectorate Changes and FY 23 results updateApril 11, 2024 | actusnews.comUpdate on Taiwanese divestmentFebruary 6, 2024 | actusnews.comNovacyt SA NYZJanuary 30, 2024 | morningstar.comTrading updateJanuary 25, 2024 | actusnews.comReminder to shareholders re. AGM votingSeptember 30, 2023 | actusnews.comCancellation of trading of Yourgene SharesSeptember 11, 2023 | actusnews.comNotice of rescheduled AGMAugust 29, 2023 | actusnews.comYourgene jumps 143% on Novacyt £16.7m knock-out bidJuly 3, 2023 | proactiveinvestors.comChipotle Mexica Share ChatJune 24, 2023 | lse.co.ukNordtelekom Nyr Share ChatJune 14, 2023 | lse.co.ukCalipso Oradea Share ChatJune 12, 2023 | lse.co.ukPublication of Annual Report and AGM votingMay 26, 2023 | actusnews.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): DHSC Claim Update – Trial Date ListedJanuary 30, 2023 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group") Full Year 2022 Trading UpdateJanuary 26, 2023 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Non-Executive Director ChangeDecember 7, 2022 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of genesig® COVID-19 3G PCR Test in the UK Under CTDA LegislationDecember 6, 2022 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Directorate ChangeNovember 10, 2022 | finance.yahoo.comNovacyt gains UK approval for its multiplex PCR test for detection of winter virusesOctober 26, 2022 | proactiveinvestors.comNovacyt approved for COVID and winter viruses PCR testOctober 26, 2022 | proactiveinvestors.comYour three-minute digest - The TimesOctober 10, 2022 | thetimes.co.ukNovacyt Faces $150 Million Legal Claim For Inconsistent COVID-19 Testing Results In UK - Marketscreener.comOctober 10, 2022 | marketscreener.comNovacyt subject to legal claim after 'troubling' Covid test results - The TimesOctober 9, 2022 | thetimes.co.ukOutlook on the High-Resolution Melting Analysis Global Market to 2027 - Featuring Agilent Technologies, Azura Genomics, Illumina and Novacyt Among Others - ResearchAndMarkets.com - Business WireOctober 6, 2022 | businesswire.comNovacyt S.A. 2022 Q2 - Results - Earnings Call Presentation (OTCMKTS:NVYTF) - Seeking AlphaOctober 1, 2022 | seekingalpha.comEARNINGS UPDATES: Volvere says interim performance... - MorningstarSeptember 29, 2022 | morningstar.co.ukNovacyt 1H Pretax Loss Narrowed Despite Major Revenue Decline - MarketWatchSeptember 29, 2022 | marketwatch.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Half Year 2022 Results - Business WireSeptember 29, 2022 | businesswire.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Half Year 2022 ResultsSeptember 29, 2022 | finance.yahoo.comRapid Plasma Reagin Test Market to observe USD 46.28 Mn incremental growth -- Driven by increasing incidence of syphilis - PR NewswireSeptember 21, 2022 | prnewswire.comUK Gov't Sues COVID-19 Test Designer For £135M - Law360August 31, 2022 | law360.comGlobal Organ Transplant Diagnostics Market to 2031 - Featuring Abbott Laboratories, ARUP Laboratories, BAG Health Care and bioMerieux Among Others - Yahoo FinanceAugust 12, 2022 | finance.yahoo.comOutlook on the Organ Transplant Diagnostics Global Market to 2031 - High Demand for Molecular Diagnostic Tests is Driving Growth - ResearchAndMarkets.com - Business WireAugust 10, 2022 | businesswire.comTRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim - MorningstarAugust 6, 2022 | morningstar.co.ukNovacyt Launches New Covid-19 PCR Assays - MarketWatchAugust 4, 2022 | marketwatch.comLaunch of Novacyt's first fully lyophilised PROmate® assays - Business WireAugust 4, 2022 | businesswire.comTRADING UPDATES: Scottish American outperforms; Amte picks Dundee | Financial News - London South EastJuly 28, 2022 | lse.co.ukNovacyt S.A. (“Novacyt”, the “Company” or the “Group”): Launch of Research-Use-Only Adenovirus F41 Assay - Business WireJuly 28, 2022 | businesswire.com Get Novacyt News Delivered to You Automatically Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address 2024 Election Year Stocks: Uncover Hidden Gems! (Ad)In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss. Secure your copy now by clicking this link. NCYT Media Mentions By Week NCYT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NCYT News Sentiment▼0.000.36▲Average Medical News Sentiment NCYT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NCYT Articles This Week▼00▲NCYT Articles Average Week Get Novacyt News Delivered to You Automatically Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EKF Diagnostics News Creo Medical Group News Inspiration Healthcare Group News Surgical Innovations Group News Smith & Nephew News NIOX Group News MaxCyte News Scancell News Futura Medical News Diaceutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:NCYT) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredA huge crack is forming in the US economyFormer Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on...Wide Moat Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novacyt S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novacyt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NCYT Stock Alerts